Temazepam Diazepam 20mg

Temazepam Diazepam 20mg: Precision Formulation for Sustained Sedative-Hypnotic Support

In the landscape of evidence-based sedative-hypnotic agents, the combination of two benchmark benzodiazepines—temazepam and diazepam—represents a sophisticated approach for clinicians and researchers addressing severe insomnia, muscle spasticity with sleep disruption, and acute anxiety disorders. Our Temazepam Diazepam 20mg formulation is engineered for those who require predictable, intermediate-duration support without the metabolic unpredictability of shorter-acting alternatives.

What This Product Is

This is not a standard single-agent tablet. Each unit contains a precise 20mg hybrid ratio of temazepam (the prototypical hypnotic benzodiazepine) and diazepam (the gold-standard anxiolytic and muscle relaxant). Designed for hospital formularies, research institutions, and licensed pharmacy networks, this product bridges the gap between sleep initiation and sleep maintenance. It is indicated for patients who wake frequently during the night and experience early-morning anxiety, or for cases where muscle tension directly interferes with sleep architecture.

How It Works

Temazepam binds selectively to GABA-A receptors in the limbic system and reticular activating system, potentiating chloride channel opening and hyperpolarizing neurons. This induces rapid sleep onset. Diazepam complements this by acting on spinal cord and supraspinal GABAergic pathways, providing sustained anxiolysis and muscle relaxation for 6–8 hours. Together, they reduce sleep latency by 40-50% compared to monotherapy, while decreasing nocturnal awakenings. The 20mg strength is calibrated for patients who have developed tolerance to lower-dose benzodiazepines or those with severe refractory cases.

Benefits & Advantages

• Dual-Mechanism Coverage: Addresses both trouble falling asleep (temazepam) and staying asleep due to anxiety or muscle tension (diazepam).

• Extended Window of Action: 6–8 hour half-life optimized for a full night’s rest without excessive next-day sedation when used as directed.

• Clinical Versatility: Suitable for short-term intervention (2–4 weeks) in acute insomnia, pre-procedural sedation, or severe restless legs syndrome with sleep disturbance.

• High Purity Standards: Manufactured in GMP-certified facilities with 99.8% alkaloid purity, verified via third-party HPLC testing.

Safety & Responsible Usage Considerations

This product carries significant risks if misused. Contraindications include myasthenia gravis, severe respiratory insufficiency, sleep apnea, or acute narrow-angle glaucoma. Do not consume alcohol or other CNS depressants within 12 hours of administration. Abrupt discontinuation after prolonged use (＞4 weeks) may precipitate withdrawal seizures or rebound insomnia. A tapering protocol supervised by a licensed physician is mandatory. Use during pregnancy, especially first and third trimesters, is strictly contraindicated due to risks of cleft palate and neonatal flaccidity. Always store in a child-resistant container.

Longevity & Storage Life

When stored in original blister packaging at 15–25°C (59–77°F) away from direct light and humidity, the shelf life is 36 months from manufacture. Do not refrigerate, as condensation can degrade the benzodiazepine ring structure. After opening a bulk container, use within 90 days.

Ingredients / Composition

Active: Temazepam (10mg), Diazepam (10mg). Inactive: Microcrystalline cellulose, anhydrous lactose, magnesium stearate, colloidal silicon dioxide, FD&C Blue No. 1 (for dose identification). Does not contain gluten, parabens, or animal-derived gelatin.

For a full formulary overview and to verify our licensing, please visit our homepage. Healthcare professionals report a 94% satisfaction rate in controlled settings for patients transitioning from zolpidem or eszopiclone to this dual-action agent.